Asbestos and cancer: An overview of current trends in Europe. by Albin, M et al.
Asbestos and Cancer: An Overview ofCurrentTrends in Europe
Maria Albin, Corrado Magnani,2 Srmena Krstev,3 Elisabetta Rapiti,4 and Ivetta Sheferl*
'Department of Occupational and Environmental Medicine, Lund University Hospital, Lund, Sweden; 2Cancer Epidemiology Unit - CPO
Piemonte, S. Giovanni B. Hospital and University ofTorino, Torino Italy; 31nstitute of Occupational and Radiological Health, Belgrade,
Yugoslavia; 4Osservatorio Epidemiologico Regione Lazio, Rome, Italy
This review assesses the contribution of occupational asbestos exposure to the occurrence of
mesothelioma and lung cancer in Europe. Available information on national asbestos
consumption, proportions of the population exposed, and exposure levels is summarized.
Population-based studies from various European regions on occupational asbestos exposure,
mesothelioma, and lung cancer are reviewed. Asbestos consumption in 1994 ranged, per capita,
between 0.004 kg in northern Europe and 2.4 kg in the former Soviet Union. Population surveys
from northern Europe indicate that 15 to 30% of the male (and a few percent of the female)
population has ever had occupational exposure to asbestos, mainly in construction (75% in
Finland) or in shipyards. Studies on mesothelioma combining occupational history with biologic
exposure indices indicate occupational asbestos exposure in 62 to 85% of the cases. Population
attributable risks for lung cancer among males range between 2 and 50% for definite asbestos
exposure. After exclusion of the most extreme values because of methodologic aspects, most of
the remaining estimates are within the range of 10 to 20%. Estimates of women are lower.
Extrapolation of the results to national figures would decrease the estimates. Norwegian
estimates indicate that one-third of expected asbestos-related lung cancers might be avoided if
former asbestos workers quit smoking. The combination of a current high asbestos consumption
per capita, high exposure levels, and high underlying lung cancer rates in Central Europe and the
former Soviet Union suggests that the lung cancers will arise from the smoking-asbestos
interaction should be a major concern. - Environ Health Perspect 107(Suppl 2):289-298 (1999).
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Asbestos exposure can induce malignant
and nonmalignant diseases. This article
only addresses the former, and it is further
restricted to those diseases unequivocally
associated with asbestos, that is, mesothe-
lioma and lung cancer. These diseases are
induced by all commercial asbestos quali-
ties (chrysotile, amosite, crocidolite, and
anthophyllite) and by tremolite, with
exposure-response patterns determined by
fiber size and fiber type (1).
This article reviews the contribution of
occupational asbestos exposure to the
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occurrence of mesothelioma and lung
cancer in Europe through a summary of
available information on national asbestos
consumption, proportion of the pop-
ulation exposed, and exposure levels.
Population-based studies from various
European regions on occupational asbestos
exposure, mesothelioma, and lung cancer
are reviewed to present information on
population-attributable risk.
Asbestos Exposure in Europe
Asbes ning
Europe has long been an important
producer of asbestos. Major chrysotile
mines are or have been active in the
USSR and in Italy, Greece, Cyprus, and
Yugoslavia; Finland has been the only
commercial producer ofanthophyllite. In
1986 significant production took place in
Italy, Greece, Cyprus, and Yugoslavia, for a
total output of 2,688,000 tons, corre-
sponding to 63% of world production.
Asbestos mining in the world has sharply
declined since 1990. The European share
declined even further, from 63% ofworld
production in 1986, to 58% in 1990, and
35% in 1996 (Table 1).
Some ofthe European asbestos producers
have stopped the mining activity, such as
Finland in 1975 (2), Cyprus in 1988 (3),
and Italy in 1990 (4). Presently, Russia is
the only significant producer ofasbestos in
Europe and the most important producer
in the world (Table 1).
Trends inAsbestos Consumption
Industrial use ofasbestos started 100 years
ago, but became widespread during and
after the Second World War. World
asbestos consumption peaked in the mid-
1970s and has since been decreasing. The
latest available statistics for Europe refer to
1996: The world output was then approxi-
mately 2.2 million tons, most being
chrysotile and only a few percent amphi-
bole asbestos. Available sources refer to
chrysotile as the only asbestos type mined
in Europe. The main part of the asbestos
output is used in the manufacturing of
asbestos cement products [85% ofthe out-
put globally (3); 85-90% within the
European Union (5)].
Domestic consumption of asbestos
decreased from 1986 to 1994 by 94% in
Northern Europe, 76% in Western
Europe, 82% in Mediterranean Europe,
69% in Central Europe, and 69% in the
former Soviet Union. However, time
trends in asbestos consumption are het-
erogeneous throughout Europe. The
decrease started in northern and Western
Europe, followed by the Mediterranean
region and, after 1990, also by Central
Europe and the former Soviet Union. The
consumption of asbestos per capita in
1990 ranged from 0.07 kg in Northern
Europe to 7.0 kg in the former Soviet
Union. In 1994 the rank of the European
regions was unchanged, but the range was
between 0.004 and 2.4 kg (Table 2).
ProportionExposed inthePopulation
Direct information on the proportion of
workers exposed to asbestos is available
from some ofthe European countries only
and is provided by ad hoc surveys, which
have been conducted mostly in the Nordic
countries, and from case-control studies.
Occupational asbestos exposure in the
general population was studied in astratified
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Country 1986 1990 1996
Bulgaria 300 300a 500
Czechoslovakia 247 ? ?
Cyprus 13,011 - - Greece 51,355 65,993 78,000
Italy 115,208 20,000a -
Former Soviet Union 2,500,000a 2,300,000a 720,000a
Yugoslavia 8,596 6,578 1,179
Europe total 2,688,717 2,392,871 799,679
World total 4,300,000 4,100,000 2,290,000
Symbols: ?, unknown; -, no production. &Estimated production. Information from British Geological Survey (71).
Also, some asbestos has been mined in Romania with an estimated outputof4,600 tons in 1989(71).
Table 2. Domestic asbestos consumption in tonsfrom 1986 to 1994 byEuropean region.ab
1986 1990 1994
Region (population x106) Total, tons Percapita, kg Total, tons Percapita, kg Total, tons Percapita, kg
Northem(18.6) 13,503 0.7 1,395 0.07 765 0.004
Western (234.8) 266,882 1.1 139,208 0.6 63,373 0.3
Mediterranean (143.9) 276,754 1.9 177,010 1.2 49,277 0.3
Central (87.7) 160,500 1.8 119,393 1.4 49,956 0.6
Former Soviet Unionc(285.9) 2,231,500 7.8 2,096,300 7.3 687,100 2.4
&Northern - Denmark, Finland, Sweden; Western - Ireland, U.K., Germany (FR and DR), France, Austria,
Switzerland, Netherlands, Belgium, Luxembourg; Mediterranean-Portugal, Spain, Italy, Greece, Yugoslavia,
Albania; Central - Poland, Czechoslovakia, Hungary, Romania, Bulgaria. bData from British Geological Surveys
(71). cEstimated production.
sample of 1275 subjects 18 to 73 years of
age in Hordaland county, Norway (which is
10% ofthe Norwegian population). The
lifetime prevalence ofasbestos exposure
reported at interview was 36% among men
and 1% among women. It was associated
with age, and was most prevalent (42%)
among men 55 to 73 years ofage (6).
A survey of men 40 years of age and
over in nine municipalities in the county
ofTelemark estimated from self-adminis-
tered questionnaires that 18% ofthe sub-
jects had former asbestos exposure.
Current and former smokers were more
prevalent among those exposed to
asbestos. On the basis of an interview with
a subset ofthe subjects, the authors con-
cluded that the questionnaire had a low
sensitivity (but a high specificity) for
asbestos exposure and that the real propor-
tion ofexposed men was probably 28 to
37% (7).
Malmberg and Hillerdal (8) found in a
general health survey of men in the county
ofUppsala, Sweden, which has a low pro-
portion ofits population employed in indus-
try, that 7% ofthe men reported exposure to
asbestos (self-administered questionnaire).
A national survey in Finland estimated
from the occupational title that 14% ofmen
35 years of age or more had significant
asbestos exposure (9). A similar estimate
was obtained for the Helsinki area, based
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on the lung tissue concentrations of
asbestos fibers (10). The proportion of
men with lung tissue concentrations indi-
cating occupational exposure showed a
clear age dependence (approximately 10%
among men 40-49 years of age and 30%
among men older than 60 years ofage).
In another study conducted from
1978 to 1981 on a population sample
(n = 8000) representative of the Finnish
population 30 years of age and over, 13%
ofthe men and 0.8% ofthe women were
classified according to thejob title as prob-
ably exposed to asbestos (11). Virtually
all had been exposed as construction or
shipyardworkers.
Thirty-six percent of male hospital
referents in London reported ever having a
job (held for at least 6 months) that was
assessed from the occupational title to
include definite or probable asbestos expo-
sure, and 20% had had such exposure for
at least 10 years. Only 3% ofthe women
had ajob with definite orprobable asbestos
exposure. The study was conducted in a
London area where asbestos exposure,
according to the authors, is "known to be
high" (12). As in the study by Hilt et al.
(7), sensitivity for self-reported asbestos
exposure was probably poor. Only 45% of
the patients classified as asbestos exposed
based on their occupational title reported
that they had worked with the material.
The specificity may have been better, as
only 16% reported exposure, although
their occupational title did not indicate
it (12).
Information on the prevalence of
asbestos exposure is also provided by popu-
lation-based andhospital-based case-control
studies (Tables 3, 4, respectively). The
prevalence ofdefinite exposure among the
controls rangesfrom 2 to 15%.
Downstream Use
Most of the available information on
exposure levels and effects are from asbestos
mining and manufacturing processes, but
in all countries, downstream use is also
very important in terms ofthe number of
workersexposed. For instance, in Poland it
was estimated that in 1991 a total of6000
workers were exposed in asbestos manufac-
turing and more than 12,000 in down-
stream use (13). In Finland 200,000
workers were estimated to have had an
exposure to more than 2 fibers per milliliter
air (f/ml) for at least 2 months during their
working life. Seventy-five percent ofthese
workers were exposed in the construction
industry and only 5% in asbestos products
manufacturing or in asbestosmining(9).
Current re vls
Asbestos exposure is limited in European
Community (EC) countries. According to
the European Directive ofthe EC 477/83
permissible limits are 1 f/ml for chrysotile
and 0.5 f/ml for amphiboles. Several
European countries have adopted lower
limits or banned asbestos use, such as
Denmark, Norway, Sweden, Finland,
Holland, Germany, Switzerland, Italy,
and France.
To our knowledge, no countries have
introduced a ban on asbestos in Central
and EasternEurope. Comparison with cur-
rent exposure in Western European coun-
tries is complex, as the occupational
standard for asbestos is usually given as
mass concentrations [2-8 mg/m3 (1)], and
fibers are notroutinelycounted.
As examples of current exposure, in
Yugoslavia in 1987, mean fiber concentra-
tions were 2 to 16 f/ml for textile manu-
facturing, 3 to 4 f/ml for friction materials
production, and 1 to 4 f/ml for asbestos
cement production (14). In Poland in
1994, exposure levels in the textile indus-
try were estimated to be much greater than
2 f/ml air, approximately 2 f/ml in
asbestos cement and friction products
manufacturing, and greater than 0.5 f/ml,
in downstream use (15). In Latvia in
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1994, fiber concentrations in asbestos
cement production ranged from 0.1 to 1.1
f/ml for the machine line to 1.1 to 5.2
f/ml for the milling and mixing areas (16).
Asbestos Exposure and
Cancer Risk in Europe
We estimate the impact ofasbestos exposure
on European lung cancer and mesothelioma
rates using population-based data. This
approach has previously been used to esti-
mate the proportion oflung cancer (17,18)
and bladder cancer (18) attributable to
occupational exposure. The population-
based studies on asbestos and respiratory
malignancies have rarely induded individual
dose estimates, but have the advantage of
contributing risk estimates for frequent
exposures such as downstream use. These
studies often use the occupational title as a
proxy for the intensity ofexposure and use
the duration in agiven activity to compute a
proxy for the dose. Information about fiber
type is rare. Dose-response models obtained
from mining and manufacturing cohorts are
also presented, but their use in predicting
lung cancer and mesothelioma rates in the
population is limited by the scarcity of
information on intensity and frequency of
exposure in downstream use.
Mesothelioma
Dose-ResponseAssociation. Mesothelioma
risk is determined by time since first
exposure, asbestos type, and dose. The
mesothelioma incidence (I) tyears after
starting exposure for a period ofdyears has
been estimated by the equation I(t) = kx c
x (tp-(t-d)p), where k is a constant possi-
bly dependent on fiber type among other
factors, c is the average fiber concentration
level during exposure and p is a constant
representing the power oftime since expo-
sure, to which incidence is proportional
(1). k has been estimated to be on the
order of 10-10 to 10-8, with lower values
for chrysotile than for amphibole exposure
(19). The model fit to empirical data was
reasonable. However, no measure of the
uncertainty in the estimates was presented.
From this model, combined with life table
Table3. Population attributable risksforlung cancerfrom occupational asbestos exposure as estimated from population-based case-control, case-cohort, and correlation studies.
Reference Studydesign Cases/controls Country Sex p(e( cases p(e) controls OR(95% Cl) PAR, %(95% Cl) Exposurea
Pastorinoetal., 1984(49) Popcc 204/351 Italy M 0.16 0.11 1.9(1.1-3.5) 7.6b Onlyasbestos
0.12 0.05 3.3(1.6-7.4) 8.4b Asbestos+PAHs
Pannettetal., 1985(46) Popcc 312/312 U.K. M 0.07 NA 1.0(0.5-1.9) 1.8 Moderate
0.04 1.8(0.7-4.4) High
Damber and Larsson, Pop cc 589/582 (dead) Sweden M 0.17 0.08 2.6(1.6-4.3) job See text
1987 (57) 456/453(alive) 0.17 0.15 1.1(0.7-1.7) 1.7b
Ronco etal., 1988 (47) Pop cc 126/384 Italy M 0.05 0.02 2.4(0.7-8.0) 2.8b Asbestos production
(seetext)
Parolari et al., 1992 (50) Pop cc 19/255 Italy M 0.63 0.18 6.2(2.3-21.3) 53 Exposure to amosite
in manufacturing
of insulation
De Vos Irvine etal., Corr U.K. M NA NA NA 5.7 (2.3-9.1)
1993(28)
Bovenzi etal., 1993(54) Pop cc 756/754 Italy M 0.22 0.12 1.4(1.0-1.9) 5.9 Possible
0.29 0.15 2.0(1.4-2.8) 14.1 Definite
van Loon etal., 1997 (48) Case-cohort 524 cases Netherlands M NA 0.088 2.5(1.3-4.8) 11.6 Evervs never
Subcohort= 1688 exposed
Martuzzi etal., 1998(55) Corr Italy M NA NA NA 3.9(2.1-5.7)
Magnani and Leporati, Mixed 227 cases Italy M+F 0.27(M) NA 3.07 (2.2-4.3) M 18.3(11.1-25.6)M Occupational and
1998(52) 0.21 (F) 2.05(1.0-4.3) F 10.1 (0-24.6) F domestic
Abbreviations: M, male; F, female; Pop cc, population based case-control study; case-cohort, population-based case-cohort study; Corr, correlation study; mixed, population-
based study with mixed design; p(e), proportion of cases/controls exposed to asbestos; OR, odds ratio; PAR, population attributable risk = (OR-1)/OR x p(e); NA, not
assessed/not applicable. "Categories are mutually exclusive. bCalculated from data in the publication.
Table 4. Population attributable risksforlung cancerfrom occupational asbestos exposure as estimatedfrom hospital based case-control studiesand studieswith mixeddesign.
Reference Study design Cases/controls Country Sex p(e) cases p(e) controls OR (95%CI) PAR, % Exposurea
Martischnig etal., 1977(57) Hosp cc 201/201 U.K. M 0.29 0.14 2.4(1.4-4.0) 17b
Kjuus etal., 1986(62) Hosp cc 176/176 Norway M 0.35 0.33 1.4(0.8-2.3) 99b Possible
0.13 0.06 2.8(1.2-8.7) 8.4b Low definite
0.12 0.03 4.3 (1.-12.0) 9.1b High definite
Dave etal., 1988(58) Hosp cc 62/198 Sweden M+F 0.10 0.02 3.3(1.2-10.3) 6.7b
Jarvholm etal., 1993 (59) cc mix 100/73+72 Sweden M 0.34 0.26 1.6(0.8-2.8) 13b 0.05-0.9f-y/ml
0.09 0.06 1.7(0.6-5.1) 3.7b .1 f-y/ml
Karjalainenetal., 1994(63) Hospcc 113/297 Finland M 0.23 0.15 1.7(0.8-3.2) 9.5b 1-4.99 x106f/g
0.03 0.03 5.3 (1.8-14.8) 9.3b .5.0 x 106f/g
dried lung tissue
Wilkinson etal., 1995(12) Hosp cc 271/678 U.K. M+F 0.34 0.26 1.7(1.2-2.4) 14b
Mollo etal., 1995(53) Autopsy ccc 31 /178 Italy M 0.29 0.14 4.2(1.4-12.6) 10.7 >1000 asbestos
bodies/g dried lung
tissue
Abbreviations: M, male; F, female; Hosp cc, hospital based case-control study; cc mix, case-control study with a mixed design; p(e), proportion of cases/controls exposed to
asbestos; OR, odds ratio; PAR, population attributable risk,(OR-1)/OR xp(e). 'Categories aremutuallyexclusive. hCalculated from data in thepublication. cAdenocarcinoma only.
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methods and U.S. mortality rates, it was
estimated that for an exposure of0.5 f/mI
for 20 years from age 25 years, the lifetime
risk ofmesothelioma from chrysotile expo-
sure only would be 5 per 10,000, and for a
mixed-fiber exposure (which is most
prevalent in downstream use), 27 per
10,000 (19). The influence of exposure
pattern (continuous/intermittent) has
rarely been studied. A recent French study
(20) indicated consistently higher risk for
continuous as compared to intermittent
exposure for the same cumulative dose.
However, misclassification may have
attenuated the risk more for intermittent
than continuous exposure.
Mesothelioma Incidence. McDonald
and McDonald (21) have suggested that
mesothelioma incidence in the 1950s prob-
ably was 1 to 2 per million, indicating the
background level in the absence ofsignifi-
cant asbestos exposure in the population.
In 1976, they published a population-
based review ofmore than 4,000 mesothe-
liomas from 22 countries. They used sex-
and age-specific rates from Canada as a ref-
erence and concluded that especially the
Netherlands and the United Kingdom
seemed to have a high mesothelioma bur-
den. They also identified regional hot-
spots, including Dresden, which was an
important center for asbestos production in
the German Democratic Republic, and
several centers for the shipbuilding indus-
try around Europe.
Information from the European cancer
registries indicates that mesothelioma inci-
dence has been increasing among men since
the 1960s (22). According to data pub-
lished in Cancer Incidence in Five
Continents-VII (23), 10 registries in the
world present cumulative incidence rates
for pleural malignancy in males higher than
15 per 1,000 and 7 ofthese registries are in
Europe. Usually a high male-to-female ratio
is observed (23). Mortality data from
England, Wales, and Scotland indicate that
mesothelioma deaths are increasing and
that the rates are determined by age and
birth cohort (24). Rates among women
were one order ofmagnitude lower than
among the men, but followed the same pat-
tern. For men born in the 1940s, the pre-
dicted lifetime risk was 1%. A continued
increase in mesothelioma deaths was pre-
dicted for another 15 to 25 years. Similar
trends, without any indications ofeffects of
preventive measures, due to the long
latency time for mesotheliomawas observed
in France (25) and in Sweden (26). A time
trend for pleural mesothelioma incidence
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was also observed in the area ofRotterdam
(27). Construction and related trades
accounted for 24% ofthedeaths (24).
In Clydebank, a major shipbuilding
area in Scotland with a high prevalence of
amphibole exposure in the population,
mesothelioma incidence peaked in 1989 at
a rate of 512 per million (95% confidence
interval [CI] from 265-896) (23), equal-
ing the incidence ofcolorectal cancer in
that year.
Mesothelioma risk from domestic and
environmental exposures has been studied
in different European countries. Studies
up to 1987 have been summarized earlier
(29). Magnani and co-workers observed
that mesothelioma risk was increased for
asbestos cement workers' wives (4 deaths
vs 0.5 expected) (30) and for nonoccupa-
tionally exposed residents in the town in
which the asbestos cement plant was oper-
ating (rate ratios 4-6 times higher than
observed in other regions) (31). Howel et
al. (32) observed a relative risk (RR) of5.6
(95% CI 1.9-16.5) for para-occupational
exposure and an RR of 2.0 (95% CI
0.9-4.2) for residential exposure to
asbestos in Yorkshire.
Other reports indicate an increase in
pleural malignancies in relation to asbestos
industries but do not separate cases by
route ofexposure. An increase in the inci-
dence ofprimary cancers ofthe pleura was
observed in a Croatian area with an
asbestos processing plant (33). Kogan and
Nikitina (34) reported that mesothelioma
incidence was 5-fold higher in a town with
chrysotile mining in the Ural compared to
the regional average.
Biologi Indicators oftheProportion
ofExposed Cases. Usually the proportion
ofexposed cases has been estimated from
occupational histories only. It has, how-
ever, been suggested that the work history,
ifpossible, should be supplemented with
biologic indicators of exposure. A few
studies combining these exposure indices
are available from Europe.
A study from the Helsinki area found
that 71% ofthe 21 cases in males had an
occupational history indicating past defi-
nite, probable, or possible exposure. The 2
cases in females in the study were dassified
as having had occupations with no evidence
ofasbestos exposure. Analysis oflung tissue
concentrations by scanning electron
microscopy also indicated that 71% had
had an occupational asbestos exposure
(total fiber concentrations > 1 million/gdry
tissue), but the exposed categories were not
entirely congruent. Thus, 86% ofthe cases
in males were assumed to have had at least
possible occupational asbestos exposure
either from their workhistory or fromlung
tissue fiber concentrations (35).
In astudy from the Paris area, Pairon et
al. (36) estimated fromoccupational histo-
ries that out of 131 patients with pleural
malignant mesothelioma (1 15 men, 16
women), 37% had a definite or probable
exposure to significant levels ofasbestos
dust. Exposure was also estimated by
counts of asbestos bodies with light
microscopy ofbronchoalveolar lavage fluid
or lung tissue. Asbestos body counts indi-
cating nontrivial asbestos exposure were
found in 34% of the subjects. Overall,
62% had either an occupational history
indicating significant asbestos exposure, or
a biologic sample indicating nontrivial
exposure. The authors conclude that the
results may reflect the fact that few
asbestos-processing industries are located
within the area, but also that it would have
been useful to evaluate the cases that did
not showelevated counts ofasbestos bodies
with electronmicroscopy.
In a series of 85 consecutive mesothe-
lioma (80 males, 5 females; diagnosis
accepted after review) from the area of
Lund in Southern Sweden, 76% had a his-
toryindicating asbestos exposure; 46% had
pleural plaques diagnosed bycomputerized
tomography, autopsy, thoracoscopy, or
thoracotomy; and 38% had asbestos body
counts (light microscopy) in lung tissue,
indicating definite occupational asbestos
exposure. The authors conclude that 84%
had either a history or biologic findings indicating exposure to asbestos (37).
LungCancer
Dose-Response Association. For lung
cancer, the risk is usually modeled in a
linear way. The model may beexpressed as:
standard mortality ratio (SMR) = 100 + b
(ce), where b is theslope and ce is cumula-
tive exposure (38). Contributions to the
risk from duration and intensity are
assumed to have equal weight (39).
Estimates of the slope vary considerably between studies and seem to be associated
both with fiber type(amphiboles associated
with higher risk than chrysotile) (1) and
industrial process per fiberlength [textiles
associated with higher risk than friction
products) (19), and to the prevalence of
exposure to otherlungcarcinogens such as
tobaccosmoking (40).
Ithas been assumedthattheadministered
dose wouldcorrespond to tissuedose, with-
out taking a limited clearance capacity in
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the lung into account. This may, as shown
by Smith (41), arbitrarily flatten or inflate
dose-response relations with accumulated
external dose; the first case may occur when
workers with short, intense exposures are a
significant part ofthe low-dose category,
and the second case may occur when work-
ers with intense exposure predominate in
the high-dose category. Only one study
(42) published risk estimates for different
intensities and found that a cumulative
approach, using the same data, overesti-
mated risk at low intensities. It has further
been argued that a threshold might exist
which is equivalent to the threshold for
minimal fibrosis. Some support for this the-
ory is found in epidemiologic studies of
subjects with and without small parenchy-
mal opacities at chest radiography [among
others, (38)], but has been contested in a
recent study (12).
It has been suggested that the difference
in risk associated with industrial process is
due to different distributions offiber size
(39). Thus, for mining, slope estimates for
chrysotile are approximately 0.05, for
tremolite 0.7, and for crocidolite 1.0. For
chrysotile friction products manufacturing,
the slope has been reported as 0.06, and for
chrysotile textile manufacturing as 1.0 to
2.0 (1). The U.S. Occupational Safety and
Health Administration estimated an aver-
age slope across studies of 1 (95% CI
0.3-3.0) (43). The validity of the esti-
mated slope for chrysotile asbestos has
recently been questioned (44).
The dose-response relations from
asbestos mining and manufacturing (1)
imply that for an exposure of 1 f/ml for 40
years, the estimated risk above the back-
ground will vary from 2 to 80%, accord-
ing to fiber type and process. It is also
clear from the analyses of mining and
manufacturing cohorts (1) that the
asbestos dose estimated to double the lung
cancer risk is quite high (50-2,000 f-y/ml).
It thus seems likely that only a small pro-
portion ofall occupationally exposed sub-
jects would experience such a risk, could
these estimates be transferred directly to
downstream use, for which no direct
estimate is available.
Population Attributable Risk.
Although relative risks for mesothelioma
are extremely high for some amphibole
exposures, lung cancer is the most impor-
tant asbestos-related neoplasm in terms of
excess deaths. Ratios between 1:1 and 1:10
between mesothelioma deaths and excess
lung cancers have been observed in dif-
ferent cohorts (21). In population-based
case-referent studies, a ratio of 1:2 was esti-
mated from Glasgow and the west of
Scotland (high proportion of crocidolite
exposure) (28) and a ratio of 1:5 from the
greater Helsinki area (high proportion of
anthophyllite exposure) (10).
Several estimates have been published
on the proportion oflung cancer attribut-
able to asbestos exposure in a population.
The proportion ofcases in a population
attributable to a certain factor can be esti-
mated as AR=p(e) x(RR-1)/RR, where p(e)
is the proportion ofexposed cases (45).
We present in Tables 3 and 4 the
European studies, which either presented
estimates ofthe population attributable risk
(PAR), or data that allowed us to calculate
it. All are case-control studies, except one
case-cohort study from the Netherlands,
and two studies from Scotland and Italy,
respectively, that used the association
between mesothelioma and lung cancer risk
to estimate the PAR.
Usually the studies were performed in
areas with a higher incidence of lung
cancer or a higher prevalence of asbestos
exposure than the national average and
were restricted to males. These aspects must
be considered when the results are general-
ized. A selection ofthe studies is listed in
Table 5 with the crude RR for lung cancer
in the study area in comparison with
national rates. These crude ratios should be
interpreted only as approximations, as it
was not always possibly to identify the exact
areas covered by the study. As seen from
Table 5, studies from areas with a lung
cancer rate below the national average are
less common and tend to have a lower pro-
portion ofasbestos-exposed cases and lower
PAR, compared to those covering areas
with rates above the national averages.
Further, several types of bias might
influence the risk estimates made for these
populations. The characterization ofexpo-
sure is usually based on self-reported expo-
sure or exposure reported by the next ofkin
for deceased subjects. It is likely that these
reports lack precision, which would tend to
decrease the contrast in exposure between
cases and referents. Moreover, the quality of
the information may vary between cases
and referents. In principle, two types of
information bias are likely to be of impor-
tance (and operate in opposite directions):
a) cases (and their next ofkin) might give
more consideration to occupational expo-
sures than healthy referents and thus be
more likely to recall that a certain exposure
has occurred; and b) for ahigher proportion
of cases than referents, information on the
work history may have to be obtained
from the next ofkin. Because the next of
kin probably is less well informed, it is
likely that significant exposures will be
missed more often among cases than con-
trols and bias the estimate towards the null
hypothesis (see below).
All quoted case-control studies
considered smoking either in the matching
ofcases and referents (46) or in the subse-
quent analyses (remaining studies). How-
ever, adjustment for smoking did not
usually alter the risk estimate substantially
and the effect of the adjustment was, as
previously indicated by Simonato et al.
(17), not consistent. Also, adjustments for
residential area, type ofdwelling, etc., had
little effect on the estimates. The estimates
from the case-referent studies were usually
not adjusted [except in the studies by Ronco
et al. (47) and van Loon et al. 48)] for
occupational exposure to other carcinogens.
Estimated RR values for definite
asbestos exposure are usually greater than
2. This is considerably higher than
expected from the dose-response relation-
ships observed in cohort studies ofasbestos
mining and asbestos products manufactur-
ing (see above). Estimates of the PAR
range from 1.8% (U.K.) to 53% (Italy).
The individual studies are described below.
Pastorino et al. (49) studied an area in
the Lombardy region (northern Italy) in
which 74% of the male active population
were estimated to be employed in industry,
the proportion being substantially higher
than the national average. For over halfof
the cases, information was obtained from
next ofkin. The corresponding proportion
for controls was 10%. Information was col-
lected about job title and industry for each
job held >6 months and no direct questions
were asked about specific exposures.
Exposures to asbestos, polycyclic aromatic
hydrocarbons (PAHs), and other established
lung carcinogens were classified as highly
probable, uncertain, or absent. RR values
were adjusted for tobacco consumption.
Ronco et al. (47) estimated the odds
ratio (OR) for ever being engaged in the
production ofasbestos materials for at least
6 months for males in two areas in the met-
ropolitan belt ofTurin. Both cases and con-
trols were deceased. Next ofkin were asked
about job title and industry, rather than
specific exposures. Estimates were adjusted
for cumulative cigarette consumption.
Parolari et al. (50) studied the associa-
tion between respiratory cancer and occu-
pational exposure to amosite in a small
community close to a factory producing
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Table 5. Population attributable risks for lung cancer in selected case-referent studies from definite occupational asbestos exposure by crude relative risk for lung cancer in
the studyarea in relation to national rates.
Lung cancercrude RR,
Reference Country/area p(e) cases studyarea/national ratesa PARb Sex
Crude RR <1
Damberand Larsson, 1987(57) Sweden/Norrbotten, 0.17 0.83(21.3, 18.3, 23.1/25.3) lOc M
Visterbotten, V3sternorrlannd
Dave et al., 1988(58) SESweden/Ostergbtland? 0.10 0.98(24.7/25.3) 6.7c M+F
Crude RR >1
Kjuus etal., 1986(62) Norway/Telemark, Vestfold 0.25 1.04(22.0, 30.1/25.2) 18c M
Karjalainen etal., 1994(63) Finland/Greater Helsinki 0.26 1.06(81.3/76.9) 19 M
Wilkinson etal., 1995(12) U.K./Greater London 0.34 1.06(77.5/72.9) 14C M+F
J3rvholm etal., 1993(59) Sweden/Gothenburg 0.43 1.13(28.5/25.3) 16 M
Martischnig etal., 1997(56) U.K./Tyne andWear?, Durham? 0.29 1.21 (101.3,74.8/72.9) 17C M
Pastorino etal., 1984(49) Italy/Varese 0.28 1.33(64.8/48.6) 16 M
Bovenzi etal., 1993(54) Italy/Trieste 0.29 1.53(74.6/48.6) 14 M
Abbreviations: p(e), proportion of cases exposed to asbestos; PAR, population attributable risk = (OR-1)/ORxp(e); RR, relative risk; ?, uncertainty about study area.
'Calculated from age-adjusted rates for males. Morbidity data were used for Norway, Sweden, and Finland (72), mortality data for the United Kingdom, and Italy(73). hPAR
for lowand high definite exposures (Tables 3 and 4) have been summarized. cCalculated from data in the publication.
amosite insulating material. A case-control
study was conducted that included cancer
deaths and deaths from other causes
(deaths from 1957-1986) as cases and con-
trols, respectively. Exposure was defined as
occupation in the factory according to
both official rosters and information from
senior workers. Results are presented for
the respiratory tract as a whole, with no
subdivision on laryngeal and pulmonary
cancers. No pleural mesotheliomas were
observed (51).
Magnani and Leporati (52) estimated
the mortality from lung cancer in asbestos
cement workers and in the general
population in a small town in which an
asbestos-cement factory had operated for
decades. The lists ofworkers and their
wives were linked to the lists ofresidents.
Former cohort studies ofthe workers and
their wives were used to obtain the distrib-
utions ofperson-years. Person-years for the
unexposed population were estimated
as the difference between the total and the
exposed populations.
Mollo et al. (53) estimated the associa-
tion between histologic types of lung
cancer and indicators ofasbestos exposure
(asbestos bodies in the lung tissue and
occupational history). Lung cancer cases
and controls were selected from the same
consecutive series ofautopsies carried out
from 1982 to 1992, matched by age and
sex; asbestos-related diseases were exduded.
Results are presented for adenocarcinoma
and for the other histologic types together.
Bovenzi et al. (54) studied occupational
exposure to recognized and suspected lung
carcinogens among deceased lung cancer
cases and deceased referents in Trieste,
Italy. Shipbuilding and ship repair were
predominant industrial activities in this
area, prior to and duringWorld War II. An
occupational history was obtained by tele-
phone interviews with the next of kin.
Classification of exposure was based on
occupational title and knowledge about
exposure conditions in the local industries.
Risk estimates were adjusted for tobacco
consumption and residential area. A clear
increase in the RR was observed with
increasing duration ofexposure.
Martuzzi et al. (55) studied the propor-
tion oflung cancer deaths attributable to
living in municipalities with increased
pleural neoplasm mortality in Piedmont,
Italy. Asbestos was mined in this region,
and textiles and asbestos-cement products
were manufactured.
Several studies have been conducted in
Great Britain, covering the Newcastle area
(56), Merseyside (46), Glasgow and the
west ofScotland (28), and London (12).
Martischnig et al. (56) interviewed inci-
dent cases submitted for suspected lung
cancer and matched referents submitted for
other reasons. Direct questions on asbestos
exposure were avoided. The interviewer
was aware ofthe case-referent status and
assessed the exposure. The RRestimate was
obtained from an analysis stratified for the
maximum daily cigarette consumption.
Pannett et al. (46) collected information
on occupation and industry using a postal
questionnaire sent to all male cancer
patients, 18 to 54 years ofage or, ifthey
were deceased, to their next ofkin. The
response rate was low (52%). Lung cancer
cases and controls (matched on age, county,
smoking habits, and vital status) were
selected from those who had responded to
the questionnaire. Exposure to asbestos,
chromate, cutting oils, formaldehyde, and
PAHs was assessed using a job-exposure
matrix. As an alternative approach, exposure
was graded bydirect review ofthe fulll occu-
pational histories. The estimates presented
in Table 3 were obtained with the latter
method, which was deemed more accurate.
The authors conclude that the low age of
the subjects induded in the study may have
decreased the relative risk observed from
asbestos exposure, as compared to a study
including the full age range. Remarkably,
the possible bias introduced by the low
response rate is notdiscussed.
De Vos Irvine et al. (28) estimated the
PAR for lung cancer from asbestos expo-
sure among men in Scotland in an ecologic
correlation study, adjusting for smoking
(using mortality from chronic bronchitis as
a proxy), social deprivation, and air pollu-
tion. The area studied induded Clydebank
(see mesothelioma incidence).
Wilkinson et al. (12) studied lung
cancer risk in relation to asbestos exposure
(as estimated from occupational titles held
at least 6 months) using two sets of refer-
ents with other respiratory diseases and car-
diac diseases, respectively. All were incident
cases and interviewed in person. The classi-
fication ofoccupational title employed had
been shown to discriminate best between
mesothelioma cases and controls in a for-
mer study. Occupations held within 15
years ofthe diagnosis were excluded from
the analysis. The results were essentially the
same using referents with respiratory and
cardiac diseases. Estimates were adjusted
for tobacco consumption, type ofreferral,
age, and sex (referents were not matched).
No dear increase in risk was observed with
increasing duration ofexposure.
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Studies of the PAR for lung cancer
from occupational exposures are available
from three different regions in Sweden:
northern Sweden (57), southeastern
Sweden (58), and Gothenburg (59).
Damber and Larsson (57) collected longi-
tudinal information with a postal question-
naire on occupation held at least 1 year,
industry, exposure to asbestos, and smoking
habits from relatives ofdecedents from lung
cancer (cases) and matched referents (one
set ofdead and one set ofliving referents).
The study induded different areas: mining
communities and heavy industrialized and
rural communities. Similar results were
generally obtained using the two sets ofref-
erents, except for asbestos exposure, where
no increase in riskwas observed in the com-
parison between dead cases and living refer-
ents, but was clearly evident when both
cases and referents were deceased, with a
higher risk for duration longer than
20 years. The authors suggest that the
discrepancy is due to a conservative infor-
mation bias, as living subjects are more
likely to be aware that they are exposed to
asbestos than their relatives. They do not
attempt to validate the accuracy ofreported
asbestos exposure, but the explanation
seems likely. Asbestos exposure was
reported twice as often for referents who
were alive as for those who were dead,
whereas the proportions ever holding occu-
pations including probable or possible
exposure to asbestos (plumbers, electricians,
engineers, boilermen, welders, stokers,
mechanics, turners, and seamen) are simi-
lar. Olsen (60) recalculated the estimate
obtained by Damber and Larsson (57),
stratified for source of information and
obtained an estimate ofthe PAR of 19%.
Estimates were adjusted for smoking status.
Dave et al. (58) collected information
on occupation and smoking, with a self-
administered questionnaire, from incident
lung cancer cases and matched (age, sex)
hospital referents. The study area was more
industrialized than northern Sweden. The
estimates were stratified for cumulative
tobacco consumption. The CIs were wide
because ofthe small size ofthe study.
Jarvholm et al. (59) investigated
subjects admitted forsuspected lung cancer
and included verified cancers as cases, and
subjects in which no cancer was diagnosed
as one set of referents. Another set was
selected from the population registry.
Gothenburg is an industrial city, with ship-
building as a major industry until the early
1970s. Questions were asked about differ-
ent occupational exposures (including
asbestos) and the occupational career. All
subjects were classified according to cumu-
lative asbestos exposure. Risk estimates
were adjusted for smoking habits. Similar
results were obtained with the two sets of
referents. No clear increasing trend in the
RR was observed for increasing dose, but
the CIs were wide and did not reject it.
Women were originally included in the
study, but were all allocated to the lower
dose category (<0.05 f-y/ml). If they are
included in the calculation ofthe PAR, it
will decrease to 11% for lung cancer in
both sexes.
Two other studies have been published
from Scandinavia. Kjuus et al. (61,62) in
Norway collected at interview detailed
information on the occupational history
of incident male lung cancer cases and
age-matched referents from the same
hospital ward. The areas covered by the
investigation, Telemark and Vestfold,
were reported to be somewhat more
industrialized than the national average.
Questions were asked on specific expo-
sures. Cross-classification of occupational
title and reported specific exposures
among cases and referents did not indicate
differential recall. Risk estimates were
adjusted for average smoking intensity
and urban/rural status. A significant
increase in the RR was observed with
increasing estimated asbestos exposure.
Karjalainen et al. (63) examined
pulmonary concentrations ofasbestos fibers
in surgically treated male lung cancer
patients from the greater Helsinki area and
men from the same areawho had been sub-
ject to forensic autopsy due to sudden or
unexpected death. Information on smoking
habits was obtained in personal interviews
with the cases and with next ofkin for the
referents (participation rate 56%). Subjects
with concentrations greater than 1 million
f/g dry tissue assessed with scanning elec-
tron microscopy were considered as
exposed to asbestos, in accordance with a
previous study in which that concentration
was 'highly indicative" ofpast occupational
exposure (10). Estimates ofthe RR were
adjusted for age and smoking. The esti-
mates quoted in Table 4 refer to all asbestos
fibers. The corresponding estimates for cro-
cidolite/amosite were: proportion of
exposed cases= 15.0%, proportion of
exposed controls=7.7%, OR= 1.9 (95%
CI=0.9-4.1), PAR=7.1%.
A large case-cohort study from the
Netherlands (48) estimated the PAR
among men for occupational lifetime expo-
sure to asbestos, adjusted for age, smoking,
diet, and other occupational exposures.
Cases were retrieved from a prospective
cohort ofmen born 1917 to 1931, claimed
to be fairly representative ofthe entire male
Dutch population. Exposure assessment
was made by occupational hygienists based
on job tide, industry, and calendar period.
An association between exposure category
and riskwas observed.
Among those studies, two obvious
outliers are identified on the low side, for
which methodologic issues might explain
the deviation. The study by Pannett et al.
(46) had a very low participation rate
which introduced an unknown, but possi-
bly important, bias and induded only sub-
jects up to 54 years ofage. The study by
Ronco et al. (47) estimated only the effect
of exposure in asbestos production,
whereas the other studies included expo-
sure in downstream use. On the other side,
one study (50) had a very high estimate of
the PAR. This study investigated a com-
munity with an exceptionally high propor-
tion ofthe population exposed in asbestos
work and the CIs are very wide due to a
small number ofcases. Thus the results are
more difficult to generalize than those
obtained in the otherstudies.
Interaction with Smoking. It has been
suggested that the variable pattern ofinter-
action (ranging from less than additive to
supramultiplicative) observed between
asbestos and smoking in epidemiologic
studies reflects that both are complex car-
cinogens that can affect more than one stage
ofthe lung carcinogenesis (64). Further,
smokers might have an enhanced accumula-
tion ofasbestos fibers in the airways (65)
and in theparenchyma (65, 66).
Kjuus et al. (61) estimated the etiologic
fractions for lung cancer in Telemark to be
1% for asbestos alone, 22% for smoking
and asbestos, and 61% for smoking alone.
Thus, although elimination of tobacco
smoking is most important for prevention
of lung cancer, an important prevention
can also be achieved byeliminating asbestos
exposure. Langard (67) estimated that for
3250 expected lung cancer cases in Norway
from 1995 to 2015 associated with asbestos
exposure, approximately one-third could be
prevented ifexposed current smokers quit
smoking and that each person would gain,
on average, 15 years oflife.
Future Trends in Asbestos-Related
Lung Cancer. The effect of current
asbestos exposure in Europe depends on the
proportion of the population that is
exposed, exposure levels, and the underlying
lung cancer risk. Langard (67) estimated
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that the absolute number of asbestos-
induced lung cancers would decline in
Norway from 1992 to 1993 on, as a conse-
quence of reduced exposure in the late
1970s, combined with a ban during the
1980s. Exposure in the other Scandinavian
countries has changed in a similar way and
thus a reduction is to be expected.
There is a trend toward a reduction of
asbestos use in all European regions, but
the differences in per capita consumption
ofasbestos in 1994 were still high, with the
highest levels in Central Europe and in the
former Soviet Union.
Trends in tobacco use can have a large
effect on asbestos-related lung cancer
trends. The prevalence ofmale smokers has
generally decreased in Europe during the
last decade. Few data are available on
tobacco consumption in Central Europe
and even less for the former Soviet Union;
the available information shows that ciga-
rette consumption is steadily increasing in
these countries (68). Lung cancer mortal-
ity among men is at present highest in
Hungary, Belgium, the Czech Republic,
the Russian Federation, and Poland (69).
Underlying cohort effects indicate that the
lung cancer rates will increase in Central
Europe (22).
The combination of a current high
asbestos consumption per capita, high
exposure levels, and high underlying lung
cancer rates in Central Europe suggests
that the lung cancers that will arise from
the smoking-asbestos interaction should
be a major concern.
Conclusions and Discussion
Trends in asbestos production and use
show a reduction in all European countries
but with quite different slopes. In Europe,
Russia and Greece remain the only impor-
tant asbestos producers. Domestic asbestos
consumption is still very high in the for-
mer Soviet Union, while a sharp decrease
has occurred in Northern Europe and a
moderate decrease has been noted in the
rest ofEurope.
Asbestos use is banned in several
countries in Northern, Western, and
Mediterranean Europe. Crocidolite use is
severely limited by EC regulation.
Although the trend in Western Europe is
toward enforcing lower exposure limits,
high exposure levels (mean concentration
above 1 f/ml) are still found in asbestos
production and use in Central Europe
and the former Soviet Union.
Only a small part of asbestos-exposed
workers have been engaged in asbestos
mining or manufacturing. Most workers
have been exposed in downstream use,
mainly in the construction industry
(approximately 85% of the asbestos is
processed by the asbestos-cement indus-
try) and in shipyards, but also in several
other occupations such as car mechanics
or railway workers. Those exposures have
often been overlooked (70). Little is
known also about the number ofworkers,
the exposure levels, and the intensity of
exposure in the asbestos removal industry.
Estimates of the proportions of men who
have had occupational exposure to
asbestos range from 14 to 36%; estimated
proportions for women are about one
magnitude lower.
Mesothelioma incidence is increasing
among men in Europe. Studies combin-
ing occupational history with analyses of
lung fiber content indicate that 62 to
85% of all cases have had occupational
exposure to asbestos.
Dose-response associations for lung
cancer obtained in cohort studies have
been published for asbestos mining and
manufacturing. No studies are available for
downstream use. These dose-response
associations indicate that a high dose is
needed to substantially increase the lung
cancer risk. It could be assumed that such
high doses are seldom acquired in down-
stream use. However, several population-
based case-control studies, one case-cohort
study, and two ecologic correlation studies
have investigated the association between
asbestos exposure and lung cancer. In these
studies, downstream exposures prevail, as
they are most prevalent in the population.
These studies do, overall, provide higher
risk estimates than would have been
expected from the cohort studies.
Female cases oflung cancer were, in all
studies that included both sexes, less
exposed than males. Thus, estimates ofthe
PAR that include both sexes tend to be
lower than those that include only men.
The latter are more numerous. Excluding
the outliers discussed above, eight studies of
male lung cancer that allow calculation of
the PAR from asbestos exposure provide
estimates for definite asbestos exposure
between 5.7 and 19%. Six of those give
estimates between 14 and 19%, repre-
senting the experience from industrial areas
ofItaly, Sweden, Great Britain, Norway,
and Finland. Estimates ofthe PAR includ-
ing both men and women range from 6.7
to 14%. It is difficult to estimate national
PARs from these regional studies.
Karjalainen et al. (10) suggest, based on a
comparison with mesothelioma incidence
data, that in Finland the national average
PAR for lung cancer may be less than half
of their estimate (19%) for the greater
Helsinki area. The Dutch study (48) is
assumed to be representative for the male
population of the Netherlands and
estimates the PARto be 11.6%.
Because asbestos and smoking have a
synergistic effect on lung cancer risk, a
substantial preventive effect for workers
who have already experienced asbestos
exposure can be achieved with the reduc-
tion of their smoking. Future trends for
asbestos-induced lung cancer will depend
on future consumption and exposure lev-
els, underlying lung cancer rates, and
smoking habits. Perspectives for Central
Europe and Russia are alarming from this
point ofview, as all three determinants
seem to be increased in relation to the rest
of Europe. The smoking reduction strat-
egy, however, is ineffective for mesothe-
lioma, for which asbestos is the only
known causative factor.
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